.jpg)
3 hours ago
1
Article content
DUBLIN — GC Aesthetics® (GCA), a privately-held medical technology company providing aesthetic and reconstruction solutions for global healthcare markets is pleased to announce the appointment of Mr. Luigi Ferrari as Chairman of the Board (non-executive) and Mr. Patrick Lee as Board Director, reinforcing the company’s strategic direction and long-term growth plans.
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
Article content
These appointments follow the renewed phase of partnership initiated in early 2024 with Hayfin Capital Management, a longstanding investor in GCA. This collaboration has brought fresh momentum to the company’s commitment to innovation, safety, and global expansion in aesthetic and reconstructive breast surgery.
Article content
Article content
Luigi Ferrari, a seasoned executive and investor with a proven track record in the healthcare sector, brings deep leadership experience, commercial growth expertise and industry insight. From 2012 to 2022 he was CEO of Lima Corporate, a global medical device company in the joint replacement market, acquired then by Enovis Corporation. Previous working experience includes several roles within Orthofix, the last one as President Global Orthopedics. He holds a M.Sc. in Management Engineering from the Polytechnic of Milan and successfully completed the Advanced Management Program at the Harvard Business School.
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
As non-executive Chairman, he will provide strategic oversight and support GCA’s mission to be a trusted, global leader in breast aesthetics and reconstruction.
Article content
Patrick Lee also joins the Board as Director, bringing with him a strong background in building and scaling successful businesses internationally. Over the last three decades, he has held senior roles at Advent Venture Partners and Ares Life Sciences, investment funds specializing in healthcare and at global pharma companies, Patrick holds a B.A, from Vassar College and an MBA from the Stanford Graduate School of Business. His broad experience and perspective will further enhance GCA’s ability to deliver on its global ambitions.
Article content
“We are delighted to welcome Luigi and Patrick to the Board of GC Aesthetics,” said Carlos Reis Pinto, CEO of GCA. “Their experience, strategic acumen, and commitment to patient-centered innovation will be instrumental as we accelerate our growth and strengthen our global leadership.”
Article content
With over 40 years of experience, presence in more than 70 countries, and a robust portfolio supported by long-term clinical data, GC Aesthetics the Total Breast Care™ Company, remains fully committed to delivering solutions to surgeons and improving patient outcomes around the world.
Article content
About GC Aesthetics®
Article content
GC Aesthetics® is a long-established global medical technology company that develops, manufactures, and markets a comprehensive range of proprietary aesthetic and reconstructive products.
Article content
Throughout its 40-year history, GCA® has been dedicated to advancing the science of medical aesthetics and delivering high-quality breast implants for breast augmentation and breast reconstructive surgery. We have sold more than 3 million implants across 70 countries, and our products are supported by published 10-year clinical data.
Article content
Article content
Article content
Article content
Article content
Article content
Contacts
Article content
Fara Naomi Macias
Chief Marketing Officer
[email protected]
Article content
Article content
English (US)